Impact of smoking on acute phase outcomes of myocardial infarction

Coronary Artery Disease

Volumn 22, Issue 4, 2011, Pages 217-222

  Wakabayashi, Kohei ^a   Romaguera, Rafael ^a   Laynez Carnicero, Ana ^a   Maluenda, Gabriel ^a   Ben Dor, Itsik ^a   Sardi, Gabriel ^a   Gaglia, Michael A ^a   Mahmoudi, Michael ^a   Gonzalez, Manuel A ^a   Delhaye, Cedric ^a   Torguson, Rebecca ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Acute myocardial infarction; clopidogrel; drug eluting stent; smoking

Indexed keywords

CLOPIDOGREL;

ACUTE HEART INFARCTION; ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING; STENT THROMBOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANGIOPLASTY, BALLOON, CORONARY; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; SMOKING; TICLOPIDINE; TREATMENT OUTCOME;

EID: 79955590331     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283441d28     Document Type: Article

References (20)

1. Council on Scientific Affairs. The wordwide smoking epidemic: Council reports. JAMA 1990; 263:3312-3318.
2. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991; 324:1619-1625.
3. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. Lancet 1992; 339:1268-1278.
4. Weisz G, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - the smoker's paradox revisited. Am Heart J 2005; 150:358-364. (Pubitemid 41116264)
5. Gourlay SG, Rundle AC, Barron HV. Smoking and mortality following acute myocardial infarction: Results from the National Registry of Myocardial Infarction 2 (NRMI 2). Nicotine Tob Res 2002; 4:101-107. (Pubitemid 34521102)
6. Kelly TL, Gilpin E, Ahnve S, Henning H, Ross J Jr. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 1985; 110:535-541. (Pubitemid 16031168)
7. Molstad P. First myocardial infarction in smokers. Eur Heart J 1991; 12:753-759.
8. Andrikopoulos GK, Richter DJ, Dilaveris PE, Pipilis A, Zaharoulis A, Gialafos JE, et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the smoker's paradox in a countrywide study. Eur Heart J 2001; 22:776-784. (Pubitemid 32625234)
9. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87:53-58. (Pubitemid 23019333)
10. Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowski Z, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the bsmoker's paradox Q from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26:1222-1229.
11. Grines CL, Topol EJ, O'Neill WW, George BS, Kereiakes D, Phillips HR, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91:298-303.
12. Gottlieb S, Boyko V, Zahger D, Balkin J, Hod H, Pelled B, et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol 1996; 28:1506-1513. (Pubitemid 26391857)
13. Zahger D, Cercek B, Cannon CP, Jordan M, Davis V, Braunwald E, et al. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial). Am J Cardiol 1995; 75:232-236.
14. Desai NR, Mega JL, Jiang S, Cannon CP, Sabatine MS. Interaction between cigarette smoking and clinical benefit of clopidogrel. J Am Coll Cardiol 2009; 53:1273-1278.
15. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115:2344-2351. (Pubitemid 46685903)
16. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, et al. Clinical implications of cigarette smoking in acute myocardial infarction: Acute angiographic findings and long-term prognosis. Am Heart J 1997; 134:955-960. (Pubitemid 27523002)
17. De Chillou C, Riff P, Sadoul N, Ethevenot G, Feldmann L, Isaaz K, et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: A multivariate analysis. J Am Coll Cardiol 1996; 27:1662-1668.
18. Gomez MA, Karagounis LA, Allen A, Anderson JL. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. Am J Cardiol 1993; 72:373-378. (Pubitemid 23238417)
19. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999; 36:425-438. (Pubitemid 29317490)
20. Bliden KP, Dichiara J, Lawal L, Singla A, Antonino MJ, Baker BA, et al. The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol 2008; 52:531-533.